Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |